Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience Letters

• Publication date

  2007-10-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEULET.2007.08.050PMID 17881124PMCID PMC2083574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease

  2007cited by this paper
• Survival signalling in Alzheimer's disease.

  2006cited by this paper
• NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha.

  2006cited by this paper
• NFκB-p65 Dependent Transcriptional Regulation of Glycosyltransferases in Human Colon Adenocarcinoma HT-29 by Stimulation with Tumor Necrosis Factor α

  2006cited by this paper
• Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.

  2006influential reference
• Defective Tumor Necrosis Factor-α-dependent Control of Astrocyte Glutamate Release in a Transgenic Mouse Model of Alzheimer Disease*

  2005influential reference
• Budesonide epimer R, LAU-8080 and phenyl butyl nitrone synergistically repress cyclooxygenase-2 induction in [IL-1β + Aβ42]-stressed human neural cells

  2005cited by this paper
• Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti‐inflammatory drugs

  2005cited by this paper
• Budesonide epimer R, LAU-8080 and phenyl butyl nitrone synergistically repress cyclooxygenase-2 induction in [IL-1beta+Abeta42]-stressed human neural cells.

  2005influential reference
• A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

  2005cited by this paper
• Oxidative stress-induced retinal damage up-regulates DNA polymerase gamma and 8-oxoguanine-DNA-glycosylase in photoreceptor synaptic mitochondria.

  2005cited by this paper
• Tumor necrosis factor α and interleukin‐1β stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells

  2005influential reference
• Lipid signaling in neural plasticity, brain repair, and neuroprotection

  2005cited by this paper
• Pharmacokinetics of budesonide in children with asthma

  2004cited by this paper
• Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis

  2004cited by this paper
• Prevention of experimental diffuse lamellar keratitis using a novel platelet‐activating factor receptor antagonist

  2004influential reference
• Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity

  2004cited by this paper
• alpha-Phenyl-n-tert-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain.

  2004cited by this paper
• Interplay among platelet‐activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival

  2004cited by this paper
• [Neuroprotection in brain ischemia--doubts and hopes].

  2004cited by this paper
• Neuroprotection in progressive brain disorders.

  2003influential reference
• Increased TNFα production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice

  2003influential reference
• Cyclooxygenase-2 and Presenilin-1 Gene Expression Induced by Interleukin-1β and Amyloid β42 Peptide Is Potentiated by Hypoxia in Primary Human Neural Cells*

  2002cited by this paper
• Activation of glycogen synthase kinase 3 beta (GSK‐3β) by platelet activating factor mediates migration and cell death in cerebellar granule neurons

  2001cited by this paper
• Interaction between neurone and microglia mediated by platelet‐activating factor

  2000cited by this paper
• Structural and Functional Changes in Proteins Induced by Free Radical‐mediated Oxidative Stress and Protective Action of the Antioxidants N‐tert‐Butyl‐α‐phenylnitrone and Vitamin E a

  1998cited by this paper
• Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes.

  1998cited by this paper
• In vitro hypoxia of cortical and hippocampal CA1 neurons: glutamate, nitric oxide, and platelet activating factor participate in the mechanism of selective neural death in CA1 neurons.

  1996cited by this paper

• Synthesis of Quinolinoneylnitrones and Coumarinylnitrones via a Cascade Hydroamination and Aza-MBH-Type Reaction.

  2024cites this paper
• A novel Danshensu/tetramethylpyrazine protects against Myocardial Ischemia Reperfusion Injury in rats

  2021cites this paper
• Glabridin alleviates inflammation and nociception in rodents by activating BKCa channels and reducing NO levels.

  2020cites this paper
• Functional Analysis of RELN S2486G Mutation and its Contribution to Pathogenesis of Ankylosing Spondylitis.

  2020cites this paper
• The role of inflammation in epileptogenesis

  2020cites this paper
• Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats

  2019cites this paper
• PAFR-deficiency alleviates myocardial ischemia/reperfusion injury in mice via suppressing inflammation, oxidative stress and apoptosis.

  2018cites this paper
• The role of inflammation in the development of epilepsy

  2018cites this paper
• Platelet Activating Factor Enhances Synaptic Vesicle Exocytosis Via PKC, Elevated Intracellular Calcium, and Modulation of Synapsin 1 Dynamics and Phosphorylation

  2016cites this paper
• Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism

  2016cites this paper
• Platelet-activating factor receptor (PAFR) plays a crucial role in experimental global cerebral ischemia and reperfusion.

  2016cites this paper
• Synthesis of N-methylarylnitrones derived from alkyloxybenzaldehydes and antineoplastic effect on human cancer cell lines.

  2015cites this paper
• Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures.

  2011cites this paper
• Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke

  2011cites this paper
• Research advances in PAF and its receptor antagonist

  2011cites this paper
• Chlorobenzene induces oxidative stress in human lung epithelial cells in vitro.

  2010cites this paper
• Inflammatory, Apoptotic, and Survival Gene Signaling in Alzheimer’s Disease

  2010cites this paper
• The genome-wide expression profile of Nelumbinis semen on lipopolysaccharide-stimulated BV-2 microglial cells.

  2009cites this paper
• LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat.

  2009influential citation
• LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.

  2008influential citation